Be part of the knowledge.™

Cardiology

643

LikeLikedUnlike

46-60 of 162

Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
- Rishi Wadhera, MD, MPP, Mphil
  Peer
1.00 program credits
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
- Rishi Wadhera, MD, MPP, Mphil
  Peer
1.00 program credits
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®
Bridging ASCVD Care Between Academic and Rural Settings
- Rishi Wadhera, MD, MPP, Mphil
  Peer
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  Peer
1.00 program credits
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
CME/CE
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
- Cynthia J. Bither, ACNP-BC, MSN
  Peer
- Andrea Wallace, MSN, FNP-C, HF-Cert
  Peer
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CE
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
- prof. Hiddo Heerspink
  Peer
- Jennifer B. Green, MD
  Peer
0.25 credits
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
CME/CE
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
- Robert J. Mentz, MD, FHFSA, FACC
  Peer
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
0.25 credits
advertisement
MinuteCE®
APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
- Daniel Gaudet, MD, PhD
  Peer
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 credits 9 episodes
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
CME/CE
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
- Faiez Zannad, MD, PhD
  Peer
- John McMurray, MD
  Peer
0.25 credits
FCS: Enhancing the Diagnosis
MinuteCE®
FCS: Enhancing the Diagnosis
- Daniel Gaudet, MD, PhD
  Peer
1.00 program credits
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®
APOC3 Inhibition: A Novel Approach to Lowering TGs
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
- Daniel Gaudet, MD, PhD
  Peer
- Pam R. Taub, MD, FACC, FASPC
  Peer
1.00 program credits
advertisement
SHTG: Defining the Unmet Clinical Need
MinuteCE®
SHTG: Defining the Unmet Clinical Need
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®
SHTG: Decoding the Latest Clinical Trial Outcomes
- Pam R. Taub, MD, FACC, FASPC
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®
Remnant Cholesterol: The Missing Link in ASCVD risk
- Børge G. Nordestgaard, MD, DMSc
  Peer
- Kausik Ray, MBChB, MD, MPhil
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended